Osteoprotegerin (OPG) is a secretory glycoprotein that belongs to the tumor necrosis factor receptor family and plays a role in atherosclerosis. OPG has been hypothesized to modulate vascular functions; however, its role in mediating atherosclerosis is controversial. Epidemiological data in patients with cardiovascular disease (CVD) indicate that OPG serum levels are associated with several inflammatory markers, myocardial infarction events, and calcium scores, suggesting that OPG may be causative for CVD
Background. Dyslipidemia and diabetes are two of the most well established risk factors for the deve...
Osteoprotegerin (OPG), a secreted member of the tumor necrosis factor receptor family, is a potent i...
Abstract Background Cardiovascular disease (CVD) is frequent in type 2 diabetes mellitus patients du...
Osteoprotegerin (OPG) is a secretory glycoprotein that belongs to the tumor necrosis factor receptor...
Osteoprotegerin (OPG) is a secretory glycoprotein that belongs to the tumor necrosis factor receptor...
Background and Purpose—Osteoprotegerin (OPG) is a secretory glycoprotein which belongs to the tumor ...
Background—Osteoprotegerin (OPG) is a secretory glycoprotein that belongs to the tumor necrosis fact...
Increasingly similarities between the cell biology of the vascular system and the skeletal system ar...
Abstract There are reports of link of osteoprotegerin (OPG) gene polymorphism to type-2 diabetes (T2...
Type 2 diabetes mellitus (T2DM) is an increasingly prevalent multifactorial disease that has both ge...
International audienceAmong the numerous molecules that are being studied for their potential utilit...
Osteoprotegerin (OPG), a glycoprotein traditionally implicated in bone remodelling, has been recentl...
Osteoprotegerin (OPG) is a 401 amino acid N-glycosylated protein, which is highly expressed in a lar...
Osteoprotegerin (OPG), a novel soluble member of tumour necrosis factor receptor superfamily, has be...
Osteoprotegerin (OPG) is a glycoprotein that acts as a decoy receptor for receptor activator of nucl...
Background. Dyslipidemia and diabetes are two of the most well established risk factors for the deve...
Osteoprotegerin (OPG), a secreted member of the tumor necrosis factor receptor family, is a potent i...
Abstract Background Cardiovascular disease (CVD) is frequent in type 2 diabetes mellitus patients du...
Osteoprotegerin (OPG) is a secretory glycoprotein that belongs to the tumor necrosis factor receptor...
Osteoprotegerin (OPG) is a secretory glycoprotein that belongs to the tumor necrosis factor receptor...
Background and Purpose—Osteoprotegerin (OPG) is a secretory glycoprotein which belongs to the tumor ...
Background—Osteoprotegerin (OPG) is a secretory glycoprotein that belongs to the tumor necrosis fact...
Increasingly similarities between the cell biology of the vascular system and the skeletal system ar...
Abstract There are reports of link of osteoprotegerin (OPG) gene polymorphism to type-2 diabetes (T2...
Type 2 diabetes mellitus (T2DM) is an increasingly prevalent multifactorial disease that has both ge...
International audienceAmong the numerous molecules that are being studied for their potential utilit...
Osteoprotegerin (OPG), a glycoprotein traditionally implicated in bone remodelling, has been recentl...
Osteoprotegerin (OPG) is a 401 amino acid N-glycosylated protein, which is highly expressed in a lar...
Osteoprotegerin (OPG), a novel soluble member of tumour necrosis factor receptor superfamily, has be...
Osteoprotegerin (OPG) is a glycoprotein that acts as a decoy receptor for receptor activator of nucl...
Background. Dyslipidemia and diabetes are two of the most well established risk factors for the deve...
Osteoprotegerin (OPG), a secreted member of the tumor necrosis factor receptor family, is a potent i...
Abstract Background Cardiovascular disease (CVD) is frequent in type 2 diabetes mellitus patients du...